Showing 57 results

Filters Content type: News, Editors' picks, About HIV Topic: Antibody-based treatment
The search for a cure

Immune modulator N-803 does not control HIV rebound, suggesting a combination approach is needed for a functional cure

News
6 March 2026
HIV treatment for children & young people

African paediatric studies at CROI: HIV remission in children, three bnAbs in babies, two years on injectables in teens

News
6 March 2026
The search for a cure

CROI 2026: How broadly neutralising antibodies help the immune system Video

March 2026
Antibody-based treatment

Broadly neutralising antibody plus cabotegravir maintains viral suppression for at least a year

News
2 March 2026
The search for a cure

Half the participants from placebo arm of HIV cure trial have prolonged viral load remission when given broadly neutralising antibodies

News
2 March 2026
Antibody-based treatment

CD8 cell fitness predicts who benefits most from antibody-based cure strategies

News
20 February 2026
New & experimental HIV treatments

Lenacapavir drug resistance in phase 1b study

Editor's pick
i-Base
25 November 2025
Antibody-based treatment

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study

News
10 November 2025
Antibody-based treatment

Broadly neutralising antibodies plus immune modulator may delay HIV rebound

News
21 July 2025
Antibody-based treatment

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

News
17 March 2025
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

News
12 March 2025
Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

News
12 March 2025
The search for a cure

The search for an HIV cure

About HIV
November 2023
Antibody-based treatment

Broadly neutralizing antibody treatment found to reduce viral reservoir in some infants with HIV-1

Editor's pick
Medical Xpress
12 July 2023
Injectable & long-acting HIV treatment

Going Long

Editor's pick
POZ
26 June 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option

News
28 February 2023
Injectable & long-acting HIV treatment

CROI 2023: Lenacapavir and two broadly neutralising antibodies for treatment Video

February 2023
Antibody-based treatment

Do broadly neutralising antibodies really have a future in treating HIV?

News
11 November 2022
Pharmaceutical industry

Long-suffering CytoDyn withdraws HIV approval application for leronlimab, blaming clinical research organization

Editor's pick
FierceBiotech
1 November 2022
Antibody-based treatment

GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial

Editor's pick
FierceBiotech
28 October 2022
Antibody-based treatment

ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV

Editor's pick
ViiV press release
26 October 2022
The search for a cure

A cure must be a cure for all: why more HIV cure research in Africa is needed

News
22 August 2022
The search for a cure

Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period

Editor's pick
HIV.gov
6 June 2022